Morgan Stanley reported a significant rise in second-quarter profit, driven by a surge in investment banking fees from high-profile transactions involving SpaceX, Cerebras, and Fertitta.
The bank’s investment banking division capitalized on a wave of initial public offerings and major corporate deals, marking a strong recovery in revenue generation for the unit.
This performance highlights the bank's successful pivot toward securing mandates from billionaire-backed technology unicorns, a strategy that has yielded substantial financial returns despite earlier controversies.
Wall Street investment banks collectively collected approximately $500 million in underwriting fees from SpaceX’s initial public offering alone, a transaction that has drawn sharp criticism for the uniformity of analyst coverage but remains a lucrative source of revenue.
The bank’s ability to land these "whale" clients, including Elon Musk’s ventures, has proven instrumental in boosting its bottom line.
This shift in client focus has allowed Morgan Stanley to recover from previous deal-related setbacks, such as the Twitter transaction, by diversifying its high-value mandate portfolio.